Alcon Announced CE Mark Approval and Launch of Clareon Vivity IOL in Europe, Expanding Visual Options
On March 25, 2025, Alcon, the global leader in eye care committed to enhancing vision, announced that Vivity®, the most widely implanted extended depth of focus (EDOF) intraocular lens (IOL), became available on Alcon's most advanced lens material — Clareon®. Clareon Vivity® received CE Mark approval and was set for commercial rollout in Europe.
Vivity's real-world outcomes demonstrated that patients with certain mild comorbidities — such as age-related macular degeneration (AMD), retinopathy/maculopathy, glaucoma, and dry eye — as well as those with post-...
